LGBTQ+ feds sue to restore FEHB coverage of gender affirming care
A class action lawsuit challenging the Trump administration’s campaign to block gender affirming care coverage under federal agencies’ employer-sponsored health insurance program said the move is “akin to denying continuing insulin treatment for someone with diabetes.”
A class action lawsuit challenging the Trump administration’s campaign to block gender affirming care coverage under federal agencies’ employer-sponsored health insurance program said the move is “akin to denying continuing insulin treatment for someone with diabetes.” This story matters for Government & Civic readers tracking council. Reported by govexec.com. Read the full original at the source link below.
Originally reported by govexec.com. CouncilNews curates and briefs the government & civic stories that matter. Our editorial policy →